Volume 60, Issue 1, Pages (July 2001)

Slides:

Advertisements

Similar presentations

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,

Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Central venous catheter outcomes in nocturnal hemodialysis

Beta blockers in the management of chronic kidney disease

Volume 88, Issue 5, Pages (November 2015)

Volume 56, Pages S95-S98 (November 1999)

End-stage renal disease in developing countries

Volume 56, Pages S62-S66 (November 1999)

Citrate Plasma Levels in Patients Under Regional Anticoagulation in Continuous Venovenous Hemofiltration Gerd R. Hetzel, MD, Gediz Taskaya, Christoph.

C-reactive protein and dialysis access

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

Continuous Dialysis Therapies: Core Curriculum 2016

Zaccaria Ricci, Claudio Ronco, Sergio Picardo Kidney International

Estevão Bassi, MD, Cesar B

Heparin-coated dialyzer membranes: is non-inferiority good enough?

Continuous renal replacement therapy in the critically ill patient

C-reactive protein and dialysis access

Section 5: Dialysis Interventions for Treatment of AKI

Volume 58, Issue 1, Pages (July 2000)

Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding Runolfur Palsson, John.

Methotrexate in the urine

Comorbidity and confounding in end-stage renal disease

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 68, Issue 1, Pages (July 2005)

Lipid redistribution in renal dysfunction

Volume 70, Issue 11, Pages (December 2006)

Body weight is a fluctuating parameter in hemodialysis patients

Nephrology Crosswords: Hemodialysis

Volume 71, Issue 11, Pages (June 2007)

Volume 70, Issue 12, Pages (December 2006)

Volume 70, Issue 12, Pages (December 2006)

Fructose intake as a risk factor for kidney stone disease

Volume 78, Issue 2, Pages (July 2010)

Volume 76, Issue 6, Pages (September 2009)

A physician's perseverance uncovers problems in a key nephrology study

CRRT dialysis circuit using regional citrate anticoagulation with the Gambro Prisma machine. CRRT dialysis circuit using regional citrate anticoagulation.

Cardiac arrest and sudden death in dialysis units

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 60, Issue 1, Pages (July 2001)

Abdulla K. Salahudeen, Erwin H. Fleischmann, John D. Bower

Nephrology Crossword: Glomerulonephritis

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Volume 71, Issue 12, Pages (June 2007)

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related.

Volume 73, Issue 9, Pages (May 2008)

Joachim Böhler, M.D., Johannes Donauer, Frieder Keller

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Long-term survival in renal transplant recipients with graft function

Daily nocturnal home hemodialysis

Racial differences in survival of patients on dialysis

Hemodialysis with high-calcium dialysate impairs cardiac relaxation

Organ transplantation goes to the movies

Total hip bone mass predicts survival in chronic hemodialysis patients

Does equal care give equal outcomes?

The Iranian model of living renal transplantation

Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction Malcolm F. Hand, William G. Haynes, David J.

Volume 80, Issue 10, Pages (November 2011)

Is complement a target for therapy in renal disease?

University of Alabama at Birmingham continuous venovenous hemodiafiltration (CVVHDF) protocol for 0.67 and 0.5% citrate. University of Alabama at Birmingham.

Dana V. Rizk, David G. Warnock Kidney International

Ivan D. Maya, Michael Allon Kidney International

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis Karl-Georg Fischer, M.D., Andreas van.

Familial phenotype differences in PKD11

RCA in continuous RRT: basic principles

Critical care nephrology: management of acid–base disorders with CRRT

Central venous catheter outcomes in nocturnal hemodialysis

Stephen Pastan, J. Michael Soucie, William M. McClellan

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Volume 60, Issue 1, Pages (July 2001)

Presentation transcript:

Volume 60, Issue 1, Pages 370-374 (July 2001) Simplified citrate anticoagulation for continuous renal replacement therapy Ashita J. Tolwani, M.D., Ruth C. Campbell, Margaret B. Schenk, Michael Allon, David G. Warnock Kidney International Volume 60, Issue 1, Pages 370-374 (July 2001) DOI: 10.1046/j.1523-1755.2001.00809.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Continuous venovenous hemodialysis (CVVHD) circuit diagram using 2% trisodium citrate as the regional anticoagulation. The 2% trisodium citrate is infused prefilter at an initial rate of 250 mL/h. Calcium gluconate (93mEq in 1L 5% dextrose) is infused systemically via a central venous line at initial rate of 60 mL/h. Dialysate (0.9% saline, KCl 3mmol/L, MgSO4 1mmol/L) is delivered at 1000 mL/h. Kidney International 2001 60, 370-374DOI: (10.1046/j.1523-1755.2001.00809.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Kaplan–Meier curve for dialyzer survival. Kidney International 2001 60, 370-374DOI: (10.1046/j.1523-1755.2001.00809.x) Copyright © 2001 International Society of Nephrology Terms and Conditions